Why Is Oscar Health Stock Down Today?
Oscar Health reported second-quarter earnings of $1.10 per share, versus a loss a year ago, and beat revenue estimates by more than $100 million — and jumped as much as 17.2% within minutes of the release. By the time the regular session opened, that gain had reversed into a small net decline.
- Oscar Health is down slightly today, even though it reported Q2 2026 EPS of $1.10 versus $0.49 estimated, and versus a loss a year ago.
- Revenue was $4.88 billion versus $4.75 billion estimated.
- The stock jumped as much as 17.2% in the minutes after the pre-market release, then gave back the entire move by the time the regular session was underway.
Oscar Health is trading slightly lower today, even after reporting second-quarter 2026 earnings of $1.10 per share before the market open, against a Wall Street estimate of $0.49 and a loss in the same quarter a year earlier. Revenue came in at $4.88 billion, above the $4.75 billion analysts had modeled. The stock jumped as much as 17.2% in the minutes after the pre-market release — and has since given back that entire move, trading marginally below yesterday's close.
Oscar Health sells individual health insurance plans, mostly through the ACA marketplace — a business that has been unprofitable for most of the company's public history, since insurers there must price plans against a membership pool whose health costs are hard to predict in advance. The immediate pre-market reaction to the profit swing and the raised full-year guidance was strongly positive; the reversal by the regular session suggests the market's first read was more enthusiastic than its second one, though nothing in the release itself changed between the two. For the full breakdown of today's numbers, see our dated report on the earnings release.
Sources
-
Oscar Health Swings to Q2 Profit, Revenue Rises; 2026 Revenue Outlook Reaffirmed
— MarketScreener
EPS swing to profit and raised guidance
-
Oscar Health's (NYSE:OSCR) Q2 CY2026 Sales Beat Estimates, Stock Jumps 11.8%
— StockStory
Revenue beat and stock reaction
Never miss the next market-moving story
Seven market specialists, with experience dating back to 2006, watch global markets and U.S. stocks of every size. Start Pro to get the full live feed, clear context, measured price moves, search, watchlists, and alerts.
Start Pro — $29 for 7 days Watch OSCR live -- free